Lymphoma-associated hemophagocytic syndrome (LAHS) in advanced-stage mycosis fungoides/Sézary syndrome cutaneous T-cell lymphoma - 28/07/11
Reprint requests: Liliane Laroche, MD, PhD, Department of Dermatology, Hôpital Avicenne, 125, rue de Stalingrad, 93009 Bobigny Cedex, France.Abstract |
Background |
Lymphoma-associated hemophagocytic syndrome (LAHS) is a rare clinicopathological entity. It has been described with primary cutaneous lymphomas, mostly of the subcutaneous panniculitis-like T-cell type, and only once with cutaneous T-cell lymphoma (CTCL).
Methods |
We report the cases of 5 patients with epidermotropic CTCL who developed LAHS and died shortly thereafter. Unlike LAHS associated with systemic lymphomas, these CTCL-associated LAHS were late events, occurring several years after the initial lymphoma diagnosis.
Limitations |
The small number of patients reported renders definite conclusions difficult. Further reports would be needed to confirm our statements.
Conclusion |
LAHS is probably underdiagnosed in CTCL patients with acute inflammatory symptoms suggestive of infections but should be considered, especially when cytopenia and elevated triglyceride and ferritin levels are present.
Le texte complet de cet article est disponible en PDF.Key words : cutaneous T-cell lymphoma, hemophagocytosis, lymphoma-associated hemophagocytic syndrome, mycosis fungoides, Sézary syndrome
Abbreviations used : CRP, CTCL, EBV, HLH, HPS, LAHS, LDH, MF, NK, PUVA, SS
Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
Vol 65 - N° 2
P. 404-410 - août 2011 Retour au numéro
Article précédent
- Tyrosine kinases in inflammatory dermatologic disease
- Ricardo T. Paniagua, David F. Fiorentino, Lorinda Chung, William H. Robinson
- Why are there significant differences in published narrowband ultraviolet B dosimetry recommendations? The need for national standardization of phototherapy treatment
- Madelaine M. Haddican, Tina Bhutani, Patricia B. McClelland, John Y.M. Koo
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?